MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Short-term investments$63,673K Cash and cashequivalents$34,064K Prepaid expenses andother current assets$1,483K Total property andequipment$8,354K Total current assets$99,220K Property and equipment,net$4,653K Operating leaseright-of-use assets$2,255K Other assets$1,510K Restricted cash$194K Less accumulateddepreciation$3,701K Total assets$107,832K Total liabilities andstockholders' equity$107,832K Total stockholders'equity$95,515K Total liabilities$12,317K Accumulated deficit-$293,923K Additional paid-in capital$389,396K Total currentliabilities$11,054K Operating leaseliabilities, non-current$1,263K Common stock, 0.001 parvalue 500,000,000...$38K Accumulated othercomprehensive income$4K Accrued expenses andother current...$8,740K Accounts payable$1,162K Operating leaseliabilities, current$1,152K
Balance Sheet

Acrivon Therapeutics, Inc. (ACRV)

Acrivon Therapeutics, Inc. (ACRV)

source: myfinsight.com